Genetic polymorphism of aldehyde oxidase in donryu rats

Drug Metabolism and Disposition

Volumn 35, Issue 5, 2007, Pages 734-739

  Itoh, Kunio ^a   Masubuchi, Akiko ^a   Sasaki, Takamitsu ^a   Adachi, Mayuko ^a   Watanabe, Nobuaki ^c   Nagata, Kiyoshi ^b   Yamazoe, Yasushi ^b   Hiratsuka, Masahiro ^a   Mizugaki, Michinao ^a   Tanaka, Yorihisa ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 CYANOANILINO) 6,7 DIHYDRO 7 HYDROXY 5H CYCLOPENTA[D]PYRIMIDINE; ALDEHYDE OXIDASE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; CHIRALITY; CONTROLLED STUDY; DRUG METABOLISM; ELECTROPHORESIS; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; HYDROXYLATION; MALE; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ALDEHYDE OXIDASE; AMINO ACID SUBSTITUTION; ANIMALS; BLOTTING, WESTERN; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENOTYPE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; ISOELECTRIC FOCUSING; KINETICS; LIVER; LUMINESCENT MEASUREMENTS; MALE; MONOAMINE OXIDASE INHIBITORS; NITRILES; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRIMIDINES; RATS; RATS, INBRED STRAINS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

RATTUS;

EID: 34247382521     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.011502     Document Type: Article

References (25)

1. Al-Salmy HS (2001) Individual variation in hepatic aldehyde oxidase activity. IUBMB Life 51:249-253.
2. Beedham C (2002) Molybdenum hydroxylase, in Enzyme Systems that Metabolise Drug and Other Xenobiotics (Ioannides C ed) pp 147-187. John Wiley, Chichester, UK.
3. Beedham C (1985) Molybdenum hydroxylases as drug-metabolizing enzymes. Drug Metab Rev 16:119-156.
4. Beedham C (1987) Molybdenum hydroxylases: biological distribution and substrate-inhibitor specificity. Prog Med Chem 24:85-121.
5. Beedham C (1998) Molybdenum hydroxylases, in Metabolism of Xenobiotics (Gorrod JW, Oeschlager H, and Caldwell J eds) pp 51-58. Taylor & Francis, London.
6. Beedham C (1997) The role of non-P450 enzymes in drug oxidation. Pharm World Sci 19:255-263.
7. Beedham C, Miceli JJ, and Obach RS (2003) Ziprasidone metabolism, aldehyde oxidase, and clinical implications. J Psychopharmacol 23:229-232.
8. Gluecksohn-Waelsch S, Greengard P, Quinn GP, and Teicher LS (1967) Genetic variations of an oxidase in mammals. J Biol Chem 242:1271-1273.
9. Itoh K, Yamamura M, Muramatsu S, Hoshino K, Masubuchi A, Sasaki T, and Tanaka Y (2005) Stereospecific oxidation of (S)-enantiomer of RS-8359, a selective and reversible MAO-A inhibitor, by aldehyde oxidase. Xenobiotica 35:561-573.
10. Itoh K, Yamamura M, Takasaki W, Sasaki T, Masubuchi A, and Tanaka Y (2006) Species differences in enantioselective 2-oxidation of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase. Biopharm Drug Dispos 27:133-139.
11. Iwabuchi H, Takasaki W, Kuwano H, Kobayashi T, and Tanaka Y (1998) Structural determination of rat and dog urinary metabolites of a new antidepressant RS-8359. Xenobio Metab Dispos 13:351-361.
12. Jordan CGM, Rashidi MR, Laljee H, Clarke SE, Brown JE, and Beedham C (1999) Aldehyde oxidase-catalyzed oxidation of methotrexate in the liver of guinea pig, rabbit and man. J Pharm Pharmacol 51:411-418.
13. Kitamura S, Nakatani K, Sugihara K, and Ohta S (1999a) Strain differences of the ability to hydroxylate methotrexate in rats. Comp Biochem Physiol C 122:331-336.
14. Kitamura S, Sugihara K, Nakatani K, Ohta S, O'Hara T, Nimomiya S, Green CE, and Tyson CA (1999b) Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans. UBMB Life 48:607-611.
15. Kitamura S, Sugihara K, and Ohta S (2006) Drug-metabolizing ability of molybdenum hydroxylases. Drug Metab Pharmacokinet 21:83-98.
16. Kunieda T, Kobayashi E, Tachibana M, and Ikada H (1999) A genetic linkage map of rat chromosome 9 with a new locus for variant activity of liver aldehyde oxidase. Exp Anim 48:43-45.
17. Miura H, Naoi M, Nakahara D, Ohta T, and Nagatsu T (1993) Changes in monoamine levels in mouse brain elicited by forced-swimming stress, and the protective effect of a new monoamine oxidase inhibitor, RS-8359. J Neural Transm 94:175-187.
18. Plenker A, Puchler K, and Volz HP (1997) The effects of RS-8359 on cardiovascular function in healthy subjects and depressed patients. Int Clin Psychopharmacol 12:S25-S297.
19. Puchler K, Schaffler K, and Plenker A (1997) The comparative effects of single and multiple doses of RS-8359, moclobemide and placebo on psychomotor function in healthy subjects. Int Clin Psychopharmacol 12:S17-S23.
20. Rashidi MR, Smith JA, Clarke SE, and Beedham C (1997) In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit and rat liver. Drug Metab Dispos 25:805-813.
21. Sasaki T, Masubuchi A, Yamamura M, Watanabe N, Hiratsuka M, Mizugaki M, Itoh K, and Tanaka Y (2006) Rat strain differences in stereospecific 2-oxidation of RS-8359, a reversible and selective MAO-A inhibitor, by aldehyde oxidase. Biopharm Drug Dispos 27:247-255.
22. Sugihara K, Kitamura S, and Tatsumi K (1995) Strain differences of liver aldehyde oxidase in rats. Biochem Mol Biol Int 37:861-869.
23. Takasaki W, Yamamura M, Nozaki A, Nitanai T, Sasahara K, Itoh K, and Tanaka Y (2005) Stereoselective pharmacokinetics of RS-8359, a selective and reversible MAO-A inhibitor, by species-dependent drug metabolizing enzymes. Chirality 17:135-141.
24. Wright RM, Clayton DA, Riley MG, McManaman JL, and Repine JE (1999) cDNA cloning, sequencing, and characterization of male and female rat liver aldehyde oxidase (rAOX1). J Biol Chem 274:3878-3886.
25. Yokoyama T, Karube T, and Iwata N (1989) Comparative studies of the effects of RS-8359 and safrazine on monoamine oxidase in vitro and in vivo in mouse brain. J Pharm Pharmacol 41:32-36.